ATLANTA, GA - During this time of the global pandemic, it is important to remember that patients are living with medical needs outside of Covid-19. With the critical nature of many health conditions, the work within pediatric clinical research is not only necessary, but is essential to the well-being of millions of families around the world, both today and in the future. Thankfully, iCAN's partner, WorldWide Clinical Trials has created an opportunity to hear from experts within the healthcare industry, including: Michael Murphy, MD, PhD, Chief Medical & Scientific Officer, Laurie Witherwax, Sr. Vice President of Site Activation, and iCAN's very own, Leanne West, President of iCAN and GA Tech Chief Engineer of Pediatric Technologies, and a very special young patient, Yalina Lopez, KIDS Illinois.
We invite you to join this amazing virtual "Unconference" to discuss how to continue or get started with your rare disease program in today’s COVID-19 environment. Register today at
During this open discussion, expert panelists will examine strategies for: • Pathways to patient access (Michael Murphy, MD, PhD, Chief Medical & Scientific Officer) • Feasibility in rare diseases (Laurie Witherwax, Sr. Vice President of Site Activation) • Engagement with a global children’s consortium (Leanne West, President - iCAN) • Pediatric perspective in clinical trial (Yalina Lopez, iCAN KIDS Illinois).
TimeMay 20, 2020 11:00 AM in Eastern Time (US and Canada)